About
About Jiangsu Bioperfectus Technologies Co., Ltd
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. In addition, the company offers biological technology platforms, including nucleic acid detection platforms, NGS technology platforms, POCT technology platforms, mass spectrometry technology platforms, and automated control and detection platforms. Jiangsu Bioperfectus Technologies Co., Ltd. was founded in 2010 and is headquartered in Taizhou, China.
Visit company website
5 years, 5 months ago
Jiangsu Bioperfectus Technologies Co., Ltd is currently in a long term downtrend where the price is trading 15.2% below its 200 day moving average.
From a valuation standpoint, the stock is 61.3% cheaper than other stocks from the None sector with a price to sales ratio of 4.8.
Jiangsu Bioperfectus Technologies Co., Ltd's total revenue rose by 550.8% to $639M since the same quarter in the previous year.
Its net income has increased by 599.7% to $238M since the same quarter in the previous year.
Based on the above factors, Jiangsu Bioperfectus Technologies Co., Ltd gets an overall score of 3/5.